DSS1 as potential prognostic marker for breast cancer progression and relapse-free patient survival

被引：0
|
作者：
Rezano, Andri [1 ,2 ]
Kuwahara, Kazuhiko [2 ]
Yamamoto-Ibusuki, Mutsuko [3 ]
Kitabatake, Masahiro [2 ]
Moolthiya, Penpak [2 ]
Phimsen, Suchada [2 ]
Suda, Taiji [4 ,5 ]
Tone, Shigenobu [4 ,5 ]
Yamamoto, Yutaka [3 ]
Iwase, Hirotaka [3 ]
Sakaguchi, Nobuo [2 ]
机构：
[1] Padjadjaran State Univ, Dept Anat & Cellular Biol, Bandung, West Java, Indonesia
[2] Kumamoto Univ, Dept Immunol, Kumamoto, Japan
[3] Kumamoto Univ, Dept Breast & Endocrine Surg, Kumamoto, Japan
[4] Kawasaki Med Sch, Dept Biochem, Kurashiki, Okayama, Japan
[5] Kawasaki Med Sch, Electron Microscope Ctr, Kurashiki, Okayama, Japan
来源：
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE | 2014年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
537
引用
下载
收藏
页码：S114 / S114
页数：1
相关论文
共 50 条
  • [1] Expression of the transcription factor Ets-1 is an independent prognostic marker for relapse-free survival in breast cancer
    Paul N Span
    Peggy Manders
    Joop J Heuvel
    Chris MG Thomas
    Remko R Bosch
    Louk VAM Beex
    CGJ (Fred) Sweep
    Oncogene, 2002, 21 : 8506 - 8509
  • [2] Expression of the transcription factor Ets-1 is an independent prognostic marker for relapse-free survival in breast cancer
    Span, PN
    Manders, P
    Heuvel, JJ
    Thomas, CMG
    Bosch, RR
    Beex, LV
    Sweep, CGJ
    ONCOGENE, 2002, 21 (55) : 8506 - 8509
  • [3] Breast cancers with high DSS1 expression that potentially maintains BRCA2 stability have poor prognosis in the relapse-free survival
    Rezano, Andri
    Kuwahara, Kazuhiko
    Yamamoto-Ibusuki, Mutsuko
    Kitabatake, Masahiro
    Moolthiya, Penpak
    Phimsen, Suchada
    Suda, Taiji
    Tone, Shigenobu
    Yamamoto, Yutaka
    Iwase, Hirotaka
    Sakaguchi, Nobuo
    BMC CANCER, 2013, 13
  • [4] Breast cancers with high DSS1 expression that potentially maintains BRCA2 stability have poor prognosis in the relapse-free survival
    Andri Rezano
    Kazuhiko Kuwahara
    Mutsuko Yamamoto-Ibusuki
    Masahiro Kitabatake
    Penpak Moolthiya
    Suchada Phimsen
    Taiji Suda
    Shigenobu Tone
    Yutaka Yamamoto
    Hirotaka Iwase
    Nobuo Sakaguchi
    BMC Cancer, 13
  • [5] Clusterin Overexpression and Relapse-free Survival in Breast Cancer
    Yom, Cha Kyong
    Woo, Hee-Yeon
    Min, Sun Young
    Kang, So Young
    Kim, Hee Sung
    ANTICANCER RESEARCH, 2009, 29 (10) : 3909 - 3912
  • [6] A Prognostic Immunoscore for Relapse-Free Survival Prediction in Colorectal Cancer
    Wang, Haizhou
    Xu, Fei
    Zhang, Meng
    Liu, Jing
    Wang, Fan
    Zhao, Qiu
    DNA AND CELL BIOLOGY, 2020, 39 (07) : 1181 - 1193
  • [7] Soluble Interleukin-6 Receptor is a Prognostic Marker for Relapse-Free Survival in Estrogen Receptor-Positive Breast Cancer
    Won, Hye Sung
    Kim, Young Ae
    Lee, Jun Sang
    Jeon, Eun Kyoung
    An, Ho Jung
    Sun, Der Sheng
    Ko, Yoon Ho
    Kim, Jeong Soo
    CANCER INVESTIGATION, 2013, 31 (08) : 516 - 521
  • [8] RELAPSE-FREE SURVIVAL IS NOT A GOOD MEASUREMENT OF SURVIVAL IN BREAST-CANCER - REPLY
    STRENDER, LE
    WALLGREN, A
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1982, 8 (10): : 1815 - 1815
  • [9] HIF-2α as a prognostic marker for breast cancer progression and patient survival
    Wang, H. X.
    Qin, C.
    Han, F. Y.
    Wang, X. H.
    Li, N.
    GENETICS AND MOLECULAR RESEARCH, 2014, 13 (02): : 2817 - 2826
  • [10] MiR-27 as a Prognostic Marker for Breast Cancer Progression and Patient Survival
    Tang, Wei
    Zhu, Jiujun
    Su, Shicheng
    Wu, Wei
    Liu, Qiang
    Su, Fengxi
    Yu, Fengyan
    PLOS ONE, 2012, 7 (12):
12345